Back
Ryan Specialty Holdings Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
74
RYAN
Ryan Specialty Holdings
Last Price:
57.92
Seasonality Move:
10.12%
Sell
47
RARE
Ultragenyx Pharmaceutical
Last Price:
41.06
Seasonality Move:
-0.9%
Buy
74
Ryan Specialty Holdings (RYAN)
is a Buy
Is Ryan Specialty Holdings a Buy, Sell or Hold?
- The current Ryan Specialty Holdings [RYAN] share price is $58.45. The Score for RYAN is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- RYAN is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $41.42. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RYAN Stock Price Chart
What is Ryan Specialty Holdings's stock price today?
-
The Ryan Specialty Holdings share price today is $58.45
The current trend is moderately bullish and RYAN is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $41.42
The current trend is relatively stagnant and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.
RYAN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.24 | Buy |
Relative Strength Index (14 RSI): | 61.42 | Buy |
Chaikin Money Flow: | 6921177 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (53.3 - 57.62) | Buy |
Bollinger Bands (100): | (48.36 - 56.14) | Buy |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.45 | Sell |
Relative Strength Index (14 RSI): | 52.47 | Buy |
Chaikin Money Flow: | 873891 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.82 - 42.02) | Buy |
Bollinger Bands (100): | (40.78 - 48.78) | Sell |
RYAN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.24 | Buy |
20-day SMA: | 55.65 | Buy |
50-day SMA: | 53.72 | Buy |
200-day SMA: | 48.73 | Buy |
8-day EMA: | 57.44 | Buy |
20-day EMA: | 55.98 | Buy |
50-day EMA: | 54.3 | Buy |
200-day EMA: | 49.67 | Buy |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.5 | Buy |
20-day SMA: | 40.58 | Buy |
50-day SMA: | 41.51 | Sell |
200-day SMA: | 42.46 | Sell |
8-day EMA: | 40.23 | Buy |
20-day EMA: | 40.49 | Buy |
50-day EMA: | 41.77 | Sell |
200-day EMA: | 43.33 | Sell |
Ryan Specialty Holdings Earnings Growth & RYAN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.25 per share, an increase this year of $0.40 per share, and an increase next year of $0.38 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.
Ryan Specialty Holdings Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |